
CRDF Valuation
Cardiff Oncology Inc
- Overview
- Forecast
- Valuation
- Earnings
CRDF Relative Valuation
CRDF's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CRDF is overvalued; if below, it's undervalued.
Historical Valuation
Cardiff Oncology Inc (CRDF) is now in the Fair zone, suggesting that its current forward PS ratio of 615.14 is considered Fairly compared with the five-year average of -5.88. The fair price of Cardiff Oncology Inc (CRDF) is between 0.53 to 8.05 according to relative valuation methord.
Relative Value
Fair Zone
0.53-8.05
Current Price:3.91
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
3.89
P/B
Median3y
1.72
Median5y
2.54
-14.98
FCF Yield
Median3y
-35.34
Median5y
-26.19
Competitors Valuation Multiple
The average P/S ratio for CRDF's competitors is 119.33, providing a benchmark for relative valuation. Cardiff Oncology Inc Corp (CRDF) exhibits a P/S ratio of 698.13, which is 485.03% above the industry average. Given its robust revenue growth of -46.83%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

NC
NACCO Industries Inc
40.070
USD
-1.69%

FUND
Sprott Focus Trust Inc
7.790
USD
-0.26%

SGMO
Sangamo Therapeutics Inc
0.586
USD
-2.01%

PLCE
Children's Place Inc
5.440
USD
-4.73%

LWLG
Lightwave Logic Inc
2.640
USD
-1.49%

ABEO
Abeona Therapeutics Inc
6.530
USD
-1.80%

BPRN
Princeton Bancorp Inc
31.700
USD
+0.51%

RCEL
AVITA Medical Inc
5.770
USD
-3.51%

FLYX
Flyexclusive Inc
2.380
USD
+0.42%

CRD.B
Crawford & Co
10.500
USD
+2.94%
FAQ

Is Cardiff Oncology Inc (CRDF) currently overvalued or undervalued?
Cardiff Oncology Inc (CRDF) is now in the Fair zone, suggesting that its current forward PS ratio of 615.14 is considered Fairly compared with the five-year average of -5.88. The fair price of Cardiff Oncology Inc (CRDF) is between 0.53 to 8.05 according to relative valuation methord.

What is Cardiff Oncology Inc (CRDF) fair value?

How does CRDF's valuation metrics compare to the industry average?

What is the current P/B ratio for Cardiff Oncology Inc (CRDF) as of Jul 26 2025?

What is the current FCF Yield for Cardiff Oncology Inc (CRDF) as of Jul 26 2025?

What is the current Forward P/E ratio for Cardiff Oncology Inc (CRDF) as of Jul 26 2025?
